SARTORE, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.653
AS - Asia 2.220
EU - Europa 1.819
SA - Sud America 538
AF - Africa 505
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 24
Totale 11.817
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.394
SG - Singapore 711
CN - Cina 479
HK - Hong Kong 381
IT - Italia 375
BR - Brasile 344
DE - Germania 197
FI - Finlandia 172
UA - Ucraina 131
FR - Francia 123
GB - Regno Unito 100
PL - Polonia 93
VN - Vietnam 93
SE - Svezia 80
RU - Federazione Russa 62
IN - India 49
NL - Olanda 49
CI - Costa d'Avorio 37
AR - Argentina 35
AT - Austria 35
ZA - Sudafrica 31
IE - Irlanda 29
EC - Ecuador 26
RO - Romania 24
RS - Serbia 24
TR - Turchia 24
ID - Indonesia 23
IQ - Iraq 23
PT - Portogallo 23
JP - Giappone 22
KR - Corea 22
IS - Islanda 21
KG - Kirghizistan 21
PE - Perù 21
AE - Emirati Arabi Uniti 20
GR - Grecia 20
VE - Venezuela 20
BB - Barbados 19
BO - Bolivia 19
CO - Colombia 19
AL - Albania 18
JM - Giamaica 18
LA - Repubblica Popolare Democratica del Laos 18
MX - Messico 18
MY - Malesia 18
PK - Pakistan 18
LC - Santa Lucia 17
MR - Mauritania 17
UZ - Uzbekistan 17
BE - Belgio 16
CY - Cipro 16
DJ - Gibuti 16
ES - Italia 16
LB - Libano 16
NI - Nicaragua 16
SD - Sudan 16
SK - Slovacchia (Repubblica Slovacca) 16
YE - Yemen 16
CA - Canada 15
CL - Cile 15
CZ - Repubblica Ceca 15
DZ - Algeria 15
ET - Etiopia 15
IL - Israele 15
LV - Lettonia 15
MK - Macedonia 15
NP - Nepal 15
NZ - Nuova Zelanda 15
TN - Tunisia 15
BA - Bosnia-Erzegovina 14
CG - Congo 14
GF - Guiana Francese 14
HN - Honduras 14
HT - Haiti 14
KH - Cambogia 14
MD - Moldavia 14
ME - Montenegro 14
MN - Mongolia 14
MZ - Mozambico 14
NC - Nuova Caledonia 14
SA - Arabia Saudita 14
SN - Senegal 14
TH - Thailandia 14
YT - Mayotte 14
ZM - Zambia 14
AM - Armenia 13
BY - Bielorussia 13
CV - Capo Verde 13
GN - Guinea 13
MA - Marocco 13
PS - Palestinian Territory 13
PY - Paraguay 13
TT - Trinidad e Tobago 13
TW - Taiwan 13
AO - Angola 12
AU - Australia 12
BS - Bahamas 12
CM - Camerun 12
CU - Cuba 12
DO - Repubblica Dominicana 12
Totale 11.272
Salva come PNG Salva come JPEG
Città #
Fairfield 912
Woodbridge 599
Ashburn 501
Chandler 446
Singapore 416
Jacksonville 398
Houston 392
Hong Kong 374
Ann Arbor 361
Seattle 354
Wilmington 324
Cambridge 317
Beijing 169
Santa Clara 153
Boardman 150
Princeton 150
San Diego 98
Des Moines 91
Roxbury 79
Medford 73
Bytom 70
Padova 61
Nanjing 57
Munich 56
Helsinki 55
Los Angeles 42
Abidjan 36
Buffalo 30
Dong Ket 28
New York 27
São Paulo 27
Milan 26
Shenyang 25
Dublin 22
Hefei 21
Ho Chi Minh City 21
Nanchang 21
Turku 21
Nuremberg 19
Vienna 19
Chicago 18
Bridgetown 17
Changsha 17
Hebei 17
London 17
Redondo Beach 17
Reykjavik 17
Bishkek 16
Brooklyn 16
Castries 16
Jinan 16
Nouakchott 16
Athens 15
Castel Maggiore 15
Djibouti 15
Guangzhou 15
Hanoi 15
Managua 15
Tashkent 15
Dakar 14
Kingston 14
Noumea 14
Riga 14
San Francisco 14
Tirana 14
Ulan Bator 14
Lusaka 13
Addis Ababa 12
Belgrade 12
Conakry 12
Johannesburg 12
Luanda 12
Nassau 12
Quito 12
Sanaa 12
Stockholm 12
Andorra la Vella 11
Bamako 11
Chisinau 11
Lauterbourg 11
Panama City 11
Phnom Penh 11
Port-au-Prince 11
Rio de Janeiro 11
Tokyo 11
Vientiane 11
Accra 10
Baku 10
Banjul 10
Dili 10
Havana 10
Kampala 10
Kingstown 10
Lappeenranta 10
Praia 10
Vicenza 10
Amman 9
Belo Horizonte 9
Brasília 9
Cayenne 9
Totale 7.811
Salva come PNG Salva come JPEG
Nome #
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 226
Impact of a mediterranean dietary pattern and its components on cardiovascular risk factors, glucose control, and body weight in people with type 2 diabetes: A real-life study 209
Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes - The TOSCA.IT study 195
Mediterranean Diet and Red Yeast Rice Supplementation for the Management of Hyperlipidemia in Statin-Intolerant Patients with or without Type 2 Diabetes 173
Long-term effect of pioglitazone vs glimepiride on lipoprotein oxidation in patients with type 2 diabetes: a prospective randomized study 165
Advanced glycation end products and antioxidant status in type 2 diabetic patients with and without peripheral artery disease 163
Low Glucose Concentrations Induce a Similar Inflammatory Response in Monocytes from Type 2 Diabetic Patients and Healthy Subjects 159
Curcumin and Boswellia serrata Modulate the Glyco-Oxidative Status and Lipo-Oxidation in Master Athletes 157
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 150
Desaturase activities and metabolic control in type 2 diabetes 149
The effects of psyllium on lipoproteins in type II diabetic patients 147
Translating the A1C assay into estimated average glucose values 145
Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients 144
Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients 142
CorrelationBetween Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in Italy. 141
The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM). 140
Between reduction of glucose fluctuations and increased therapeutic adherence: an example of the benefits of vildagliptin in an elderly diabetic patient. 135
Genetic variability of the fructosamine 3-kinase gene in diabetic patients 134
Plasma lipoproteins, apoproteins and cardiovascular disease in type 2 diabetic patients. A nine-year follow up study 134
Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes. 134
Subclinical diastolic dysfunction in type 2 diabetic patients with and without carotid atherosclerosis: Relationship with glyco-oxidation, lipid-oxidation and antioxidant status. 133
Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress 132
Bariatric surgery improves atherogenic LDL profile by triglyceride reduction 132
Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials 129
Reduced susceptibility to oxidation of low-density lipoprotein in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome) 127
Patient-reported outcomes in elderly patients with type 2 diabetes mellitus treated with dual oral therapy: a multicenter, observational study from Italy 124
Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes 123
HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study 122
Plasma phospholipid fatty acid composition and desaturase activity in women with gestational diabetes mellitus before and after delivery 122
Lipoprotein abnormalities in NIDDM with impaired extrahepatic insulin sensitivity hypertension and microalbuminuria 119
Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients? 118
Pasta consumption and connected dietary habits: Associations with glucose control, adiposity measures, and cardiovascular risk factors in people with type 2 diabetes—TOSCA.IT study 118
Long-term treatment with simvastatin in hypercholesterolemic non-insulin- dependent diabetic patients 115
High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction 115
Association of Serum Cystatin C with Cardiovascular Risk Factors in Type 2 Diabetic Patients 115
GLICAZIONE AVANZATA E OSSIDAZIONE LIPOPROTEICA: EFFETTI EXTRA-GLICEMICI DEL TRATTAMENTO CON PIOGLITAZONE IN PAZIENTI CON DIABETE TIPO 2 114
An effective and rapid determination by MALDI/TOF/TOF of methionine sulphoxide content of ApoA-I in type 2 diabetic patients. 113
Lipoprotein abnormalities in non-insulin-dependent diabetic patients with impaired extrahepatic insulin sensitivity, hypertension, and microalbuminuria 112
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes. 112
Glucose Fluctuations during Gestation: An Additional Tool for Monitoring Pregnancy Complicated by Diabetes. 112
Anti-diabetic combination therapy with pioglitazone or glimepiride added to metformin on the AGE-RAGE axis: a randomized prospective study 112
ROSES: role of self-monitoring of blood glucose and intensive education in patients with Type 2 diabetes not receiving insulin. A pilot randomized clinical trial. 111
Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update. 110
Focusing on potential sources of glucose fluctuations in type 1 and type 2 diabetes: Which kind of patient, what kind of glycemic variability and which confounding factors? 110
Omicron Variant of SARS-CoV-2 Virus: In Silico Evaluation of the Possible Impact on People Affected by Diabetes Mellitus 110
Relationship between Subclinical Diastolic Dysfunction and Lipid-and Glyco-Oxidation in Type 2 Diabetic Subjects with and without Carotid Atherosclerosis 108
Role of endogenous secretory RAGE (esRAGE) in defending against plaque formation induced by oxidative stress in type 2 diabetic patients 108
Plasma fatty acids and lipoproteins in type 2 diabetic patients 108
La glico-ossidazione nell’aterosclerosi carotidea del diabete di tipo 2 107
Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study 106
Peripheral artery disease in type 2 diabetes: the role of fibrinolysis 105
Ketoacidosis in diabetic pregnancy 104
Calf and forearm blood flow in hypercholestrolemic patients 103
Evaluation of methionine sulphoxide content of Apo A-I in type 2 diabetic patients and young coronaropathic subjects: a preliminary study 103
Glucose variability in diabetic pregnancy 103
Open questions on basal insulin therapy in T2D: a Delphi consensus 102
Lipids and diabetic nephropathy: hypertension, microalbuminuria and lipids in type 2 diabetic patients 102
Long-term treatment with simvastatin in type 2 diabetic patients. 98
Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia. 97
Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-Derived Average Glucose (ADAG) study 96
Circulating oxidized low-density lipoproteins and antibody to oxidized low-density lipoproteins in type 2 diabetic subjects: the role of glycoxidation 96
Pentosidine plasma levels and relation with metabolic control in diabetic patients 95
Acidi grassi alimentari, insulino-resistenza e lipoproteine 94
The lipoprotein composition of plasma and ascitic fluid in liver cirrhosis. 94
Dietary fatty acids, lipoproteins and insulin resistance 88
A role of glycation and methylation for SARS-CoV-2 infection in diabetes? 88
In silico evaluation of the interaction between ACE2 and SARS-CoV-2 Spike protein in a hyperglycemic environment 86
Plasma fatty acids and lipoproteins in type 2 diabetic patients 84
null 83
HDL e aterosclerosi: ruolo delle modificazioni di apoA-1 82
Increased methionine sulfoxide contento f ApoA-I in young patients with premature acute myocardial infarction and in Type 2 Diabetic patients. 78
Efficacia della dieta mediterranea con integrazione di riso rosso fermentato nel trattamento di pazienti dislipidemicicon e senza diabete di tipo 2 78
Role of fructosamine-3-kinase in protecting against the onset of microvascular and macrovascular complications in patients with T2DM 78
Immature Surfactant Protein Type B and Surfactant Protein Type D Correlate with Coronary Heart Disease in Patients with Type 2 Diabetes 77
Ruolo di endogenous secretory RAGE (esRAGE) nelle complicanze retiniche e macrovascolari perfieriche in un gruppo di pazienti diabetici di tipo 2. 77
LDL-Aferesi: confronto di metodiche 76
Ruolo di endogenous secretory RAGE nelle complicanze micro-macrovascolari di un gruppo di pazienti diabetici tipo 2. 75
Ruolo degli anticorpi anti-ox-LDL nella malattia diabetica 75
Effects of hypocaloric dietary treatment enriched in oleic acid on LDL and HDL subclass distribution in madly obese women 74
Obesità e dislipidemia 73
LDL-apheresis: Comparison of methods 72
Artificial Intelligence Algorithm to Screen for Diabetic Neuropathy: A Pilot Study 71
LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicenter Octreotide Study Group 71
Trattamento dell’Iperglicemia Mild nel Soggetto pre-diabetico e nel Paziente con Diabete Tipo 2 Intollerante a Metformina:un nuovo spazio per la nutraceutica 71
LDL OXIDATIVE STATUS IN NO OVERPRODUCTION: BARTTER'S (BS) AND GITELMAN'S (GS) SYNDROME 69
The Ankle-Brachial Index for assessing the prevalence of peripheral artery disease and cardiovascular risk in patients with type 2 diabetes mellitus 67
La dislipidemia perde di potenza di rischio con l'età? 67
Lipid profile in women of different ethnicity with gestational diabetes: Relationship with fetal growth 66
Long-term HbA1c variability and macro-/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update 66
Statine: effetti collaterali ed aderenza terapeutica 66
Predittori di microalbuminuria nel Diabete Tipo 2 65
Severe bad metabolic control in type 2 diabetes and plasma phospholipid fatty acid composition 65
Advanced glycation end-products in microvascular complications of type 2 diabetes: Are they “major actors” in metabolic memory? 64
Multiplexed MRM-based proteomics for identification of circulating proteins as biomarkers of cardiovascular damage progression associated with diabetes mellitus 63
Effect of a New Formulation of Nutraceuticals as an Add-On to Metformin Monotherapy for Patients with Type 2 Diabetes and Suboptimal Glycemic Control: A Randomized Controlled Trial 63
La sindrome plurimetabolica 60
RIDOTTA SUSCETTIBILITÀ ALL'OSSIDAZIONE DELLE LDL IN PAZIENTI CON AUMENTATA PRODUZIONE DI OSSIDO D'AZOTO 59
MONITORAGGIO CONTINUO DELLA GLICEMIA NELL'ADULTO CON DIABETE TIPO 1 58
Consensus intersocietario sull'impiego degli anticorpi anti-PCSK9 nella gestione del controllo lipidico dei pazienti con diabete mellito 57
Erratum: Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials (European Journal of Clinical Nutrition, (2016), 70, 12, (1354-1359), 10.1038/ejcn.2016.154) 57
Totale 10.600
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.374
article - articoli 37.498
book - libri 592
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 850
Totale 79.314
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021964 0 0 38 88 39 106 27 87 190 186 128 75
2021/20221.331 22 160 212 85 55 56 51 137 69 31 145 308
2022/2023936 200 94 20 105 133 149 7 66 102 6 37 17
2023/2024508 18 56 59 42 18 59 43 17 37 13 66 80
2024/20252.458 13 141 121 97 350 46 129 186 230 90 432 623
2025/20262.650 427 899 1.324 0 0 0 0 0 0 0 0 0
Totale 11.929